Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

NCT00122330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemoglobinuria, Paroxysmal

Interventions

DRUG: eculizumab

Sponsor

Alexion Pharmaceuticals, Inc.